Conquering cancer requires information and dialogue. Our print and online resources make it easy to stay up-to-date on CRI’s role in helping to advance cancer immunotherapy research and treatment. We also offer information especially for patients and their families, as well as for current and prospective donors.
For the latest news, sign up for our e-alerts or subscribe to our blog. You can also read our print publications, view our videos, and access our guides and other resources for patients for more information. If you would like more information, call us at (800) 99-CANCER or send us a message via our Contact Us page.
Our blog features the latest updates from the front lines of cancer immunotherapy, including new scientific and clinical breakthroughs, news stories, and program announcements. Read the latest stories here or go to our blog to see all of our posts and subscribe to receive alerts when new stories are posted.
December 22, 2014
| Jill O'Donnell-Tormey, Ph.D.
Just hours ago, the FDA approved Bristol-Myers Squibb's PD-1 drug for melanoma.
anti-PD-1, cancer immunotherapy, checkpoint-inhibitor, FDA approval, melanoma
December 18, 2014
| Hannah Appelbaum
This holiday season, meet five staff members who want you to know why they support CRI.
December 15, 2014
| Michelle Liew
Learn why this past year was one of many breakthroughs for CRI.
annual report, cancer immunotherapy